NEUP · Company research
Neuphoria Therapeutics Inc. (NEUP): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 3.42 | $16,044,582.4 | -3820948.60 | — | — | — | 13.6646743856272330 | 0.65221821346338633356 | 13.21788485270881012029 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.